Literature DB >> 16780220

Motility signaled from the EGF receptor and related systems.

Alan Wells1, Brian Harms, Akihiro Iwabu, Lily Koo, Kirsty Smith, Linda Griffith, Douglas A Lauffenburger.   

Abstract

Cell motility is now recognized as central to many biological processes. Growth factors, such as those that activate the epidermal growth factor receptor (EGFR), drive biochemically and biologically distinct subsets of migration critical for (neo)organogenesis and tumor invasion. Thus, modulation of these events requires an understanding of the controls of EGFR-mediated motility. Deconstruction of motility into its component events enables this deeper insight. Herein we describe methods that measure the overall motility and its parameters as well as the biophysical processes extension, de-adhesion/retraction, and contraction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780220     DOI: 10.1385/1-59745-012-X:159

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Controlling multipotent stromal cell migration by integrating "course-graining" materials and "fine-tuning" small molecules via decision tree signal-response modeling.

Authors:  Shan Wu; Alan Wells; Linda G Griffith; Douglas A Lauffenburger
Journal:  Biomaterials       Date:  2011-07-22       Impact factor: 12.479

2.  E-cadherin surface levels in epithelial growth factor-stimulated cells depend on adherens junction protein shrew-1.

Authors:  Julia Christina Gross; Alexander Schreiner; Knut Engels; Anna Starzinski-Powitz
Journal:  Mol Biol Cell       Date:  2009-06-10       Impact factor: 4.138

3.  Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.

Authors:  Pei Jin; Juan Zhang; Malgorzata Beryt; Lisa Turin; Cathleen Brdlik; Ying Feng; Xiaomei Bai; Jim Liu; Brett Jorgensen; H Michael Shepard
Journal:  Mol Med       Date:  2008-11-17       Impact factor: 6.354

4.  Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.

Authors:  Hadas Cohen-Dvashi; Nir Ben-Chetrit; Roslin Russell; Silvia Carvalho; Mattia Lauriola; Sophia Nisani; Maicol Mancini; Nishanth Nataraj; Merav Kedmi; Lee Roth; Wolfgang Köstler; Amit Zeisel; Assif Yitzhaky; Jacques Zylberg; Gabi Tarcic; Raya Eilam; Yoav Wigelman; Rainer Will; Sara Lavi; Ziv Porat; Stefan Wiemann; Sara Ricardo; Fernando Schmitt; Carlos Caldas; Yosef Yarden
Journal:  EMBO Mol Med       Date:  2015-03       Impact factor: 12.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.